Save your place

Sign in to WhoBought

Please try again later.

Elicio Therapeutics, Inc. (ELTX) institutional ownership

Latest close $3.00 Jul 24, 2026
Market cap$160M 52-week range SectorHealthcare
Funds holding · Q1 2026
43
reported ELTX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
30 buyers · 13 sellers

Elicio Therapeutics, Inc. (ELTX) price and institutional activity

Dates

Q1 2026

$0 bought by 30 investors
Balyasny Asset Management L.P.Vanguard +28 more
$0 sold by 13 investors
Marshall Wace, LLPSquarepoint Ops LLC +11 more
Bought Sold Totals per quarter; hover a bar for the names.

Elicio Therapeutics, Inc. (ELTX) institutional activity · 43

Investor Type Est. change Change Δ Own Date
Balyasny Asset Management L.P. · Added
Change +106K Date Q1 2026
Balyasny Asset Management L.P. Added· Q1 2026 +106K Q1 2026
Vanguard · Added
Change +95K Date Q1 2026
Vanguard Added· Q1 2026 +95K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +94K +332.7% Q1 2026
Millennium Management LLC · New
Change +93K Date Q1 2026
Millennium Management LLC New· Q1 2026 +93K Q1 2026
Goldman Sachs Group Inc · New
Change +58K Date Q1 2026
Goldman Sachs Group Inc New· Q1 2026 +58K Q1 2026
Marshall Wace, LLP · Reduced
Change −43K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −43K Q1 2026
Iridian Asset Management LLC · New
Change +30K Date Q1 2026
Iridian Asset Management LLC New· Q1 2026 +30K Q1 2026
Hrt Financial LP · New
Change +22K Date Q1 2026
Hrt Financial LP New· Q1 2026 +22K Q1 2026
Hudson Bay Capital Management LP · New
Change +20K Date Q1 2026
Hudson Bay Capital Management LP New· Q1 2026 +20K Q1 2026
Morgan Stanley · Added
Change +18K Date Q1 2026
Morgan Stanley Added· Q1 2026 +18K Q1 2026
Brevan Howard Capital Management LP · New
Change +17K Date Q1 2026
Brevan Howard Capital Management LP New· Q1 2026 +17K Q1 2026
Squarepoint Ops LLC · Exited
Change −17K Δ Own −100.0% Date Q1 2026
Squarepoint Ops LLC Exited· Q1 2026 −17K −100.0% Q1 2026
Citadel Advisors LLC New· Q1 2026 +16K Q1 2026
Occudo Quantitative Strategies LP · Exited
Change −16K Δ Own −100.0% Date Q1 2026
Occudo Quantitative Strategies LP Exited· Q1 2026 −16K −100.0% Q1 2026
Bank of America Corp · Added
Change +14K Date Q1 2026
Bank of America Corp Added· Q1 2026 +14K Q1 2026
Data through Q1 2026 · filed May 15, 2026
15 of 43

Famous investor activity in Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics, Inc. (ELTX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Haqq Christopher · Officer Grant (A) 65K
Owned 65K Trade date Jul 16, 2026 Filed date Jul 17, 2026
Haqq Christopher Officer Grant (A) 65K 65K Jul 16, 2026 Jul 17, 2026
Demuth Peter · Officer Grant (A) 53K
Owned 53K Trade date Jul 16, 2026 Filed date Jul 17, 2026
Demuth Peter Officer Grant (A) 53K 53K Jul 16, 2026 Jul 17, 2026
Shah Preetam · Officer Grant (A) 61K
Owned 61K Trade date Jul 16, 2026 Filed date Jul 17, 2026
Shah Preetam Officer Grant (A) 61K 61K Jul 16, 2026 Jul 17, 2026
Connelly Robert · Director Grant (A) 187K
Owned 187K Trade date Jul 16, 2026 Filed date Jul 17, 2026
Connelly Robert Director Grant (A) 187K 187K Jul 16, 2026 Jul 17, 2026
Connelly Robert · Director, Officer 2 operations 221K
Owned 147K Trade date Feb 2, 2026 Filed date Feb 3, 2026
Connelly Robert Director, Officer 2 operations 221K 147K Feb 2, 2026 Feb 3, 2026
Shah Preetam · Officer 2 operations 72K
Owned 48K Trade date Feb 2, 2026 Filed date Feb 3, 2026
Shah Preetam Officer 2 operations 72K 48K Feb 2, 2026 Feb 3, 2026
Demuth Peter · Officer 2 operations 62K
Owned 42K Trade date Feb 2, 2026 Filed date Feb 3, 2026
Demuth Peter Officer 2 operations 62K 42K Feb 2, 2026 Feb 3, 2026
Haqq Christopher · Officer 2 operations 76K
Owned 51K Trade date Feb 2, 2026 Filed date Feb 3, 2026
Haqq Christopher Officer 2 operations 76K 51K Feb 2, 2026 Feb 3, 2026
Demuth Peter · Officer 2 operations 0
Price $4.41 Owned 0 Trade date Dec 9, 2025 Filed date Dec 10, 2025
Demuth Peter Officer 2 operations $4.41 0 0 Dec 9, 2025 Dec 10, 2025
9 of 9

Elicio Therapeutics, Inc. (ELTX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Moti Investments LLC 1.4M
% of shares outstanding 6.1% Filing date Jul 16, 2026
Moti Investments LLC 1.4M 6.1% Jul 16, 2026
Knoll Capital Management, LLC 1.2M
% of shares outstanding 5.3% Filing date Jul 8, 2026
Knoll Capital Management, LLC 1.2M 5.3% Jul 8, 2026
Actyus Private Equity Sgiic, S.A. 269K
% of shares outstanding 1.6% Filing date Oct 7, 2025
Actyus Private Equity Sgiic, S.A. 269K 1.6% Oct 7, 2025
3 of 3

Elicio Therapeutics, Inc. (ELTX) ownership FAQ

Who owns ELTX?

43 reporting institutions disclosed ELTX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.